Yanbing Li Selected Research

Obesity

12/2022	Integrative analyses of hub genes and their association with immune infiltration in adipose tissue, liver tissue and skeletal muscle of obese patients after bariatric surgery.
4/2020	Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders.
7/2018	Angiopoietin-like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non-alcoholic fatty liver disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanbing Li Research Topics

Disease

27	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2003
27	Influenza in Birds (Avian Flu) 01/2022 - 09/2005
26	Neoplasms (Cancer) 01/2022 - 11/2011
14	Papillary Thyroid Cancer 01/2022 - 06/2012
11	Insulin Resistance 08/2021 - 11/2009
10	Infections 04/2022 - 01/2007
8	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 11/2011
6	Hyperglycemia 01/2022 - 11/2004
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 11/2016
6	Carcinogenesis 01/2021 - 08/2013
5	Inflammation (Inflammations) 11/2021 - 08/2005
5	Myocardial Infarction 11/2021 - 11/2016
5	Glucose Intolerance 04/2020 - 01/2016
4	Diabetes Mellitus 03/2022 - 07/2016
4	Thyroid Nodule (Nodule, Thyroid) 01/2022 - 06/2012
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
3	Obesity 12/2022 - 07/2018
3	Hypertension (High Blood Pressure) 11/2021 - 12/2017
3	COVID-19 11/2021 - 01/2020
3	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021 - 04/2016
3	Adenoma (Adenomas) 01/2021 - 12/2017
3	Graves Ophthalmopathy 01/2021 - 03/2019
3	Body Weight (Weight, Body) 01/2021 - 05/2015
3	Human Influenza (Influenza) 01/2021 - 07/2008
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 07/2018
3	Diabetic Nephropathies (Diabetic Nephropathy) 09/2016 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2019
2	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2018
2	Diabetes Complications 01/2022 - 01/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 08/2013
2	Shock 09/2021 - 06/2019
2	Dyslipidemias (Dyslipidemia) 08/2021 - 10/2020
2	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2017
2	Hypokalemia 01/2021 - 12/2017
2	Fibrosis (Cirrhosis) 01/2021 - 11/2020
2	Critical Illness (Critically Ill) 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2016
2	Lymphatic Metastasis 09/2016 - 02/2016
2	Carcinoma (Carcinomatosis) 09/2016 - 01/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2016 - 11/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 02/2015
2	Poultry Diseases (Poultry Disease) 08/2010 - 09/2009
1	Hematoma 04/2022

Drug/Important Bio-Agent (IBA)

19	Insulin (Novolin)FDA Link 03/2022 - 11/2004
19	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2012
13	Biological ProductsIBA 01/2022 - 01/2008
12	MicroRNAs (MicroRNA)IBA 07/2021 - 06/2012
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2008
10	VaccinesIBA 01/2022 - 10/2005
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
7	Pharmaceutical PreparationsIBA 01/2021 - 03/2012
6	LipidsIBA 08/2021 - 01/2016
5	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2003
5	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 01/2007
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
4	oxidized low density lipoproteinIBA 08/2021 - 01/2014
4	Triglycerides (Triacylglycerol)IBA 08/2021 - 01/2003
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 08/2013
4	Inactivated VaccinesIBA 12/2012 - 10/2005
3	CytokinesIBA 03/2022 - 07/2016
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021 - 07/2018
3	omega-Chloroacetophenone (Mace)IBA 11/2021 - 11/2016
3	LDL CholesterolIBA 08/2021 - 10/2020
3	Long Noncoding RNAIBA 07/2021 - 07/2016
3	Uric Acid (Urate)IBA 01/2021 - 01/2021
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 04/2016
3	AldosteroneIBA 01/2021 - 12/2017
3	SodiumIBA 01/2021 - 01/2021
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2020 - 09/2016
3	Peptides (Polypeptides)IBA 02/2020 - 08/2005
3	CateninsIBA 11/2019 - 11/2011
3	Amino Acids FDA Link 01/2019 - 09/2005
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 11/2016
3	EnzymesIBA 10/2017 - 02/2015
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	Aldehyde Reductase (Aldose Reductase)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2021 - 09/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2015
2	PotassiumIBA 01/2021 - 12/2017
2	Troleandomycin (TAO)FDA Link 01/2021 - 03/2019
2	Angiopoietin-Like Protein 8IBA 04/2020 - 07/2018
2	CalciumIBA 01/2019 - 07/2017
2	Insulin ReceptorIBA 09/2018 - 11/2009
2	Exenatide (Byetta)FDA Link 01/2018 - 11/2016
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2018 - 11/2016
2	Vitamin D FDA LinkGeneric 09/2016 - 01/2013
2	Liraglutide FDA Link 01/2016 - 01/2012
2	Cyclin D1IBA 02/2015 - 01/2015
2	DNA VaccinesIBA 05/2011 - 09/2007
2	Neuraminidase (Sialidase)IBA 03/2010 - 09/2009

Therapy/Procedure

24	Therapeutics 03/2022 - 01/2003
7	Glycemic Control 07/2018 - 11/2004
2	Bariatric Surgery 12/2022 - 01/2020
2	Length of Stay 04/2022 - 11/2021
2	Percutaneous Coronary Intervention 11/2021 - 01/2020
2	Photochemotherapy (Photodynamic Therapy) 10/2016 - 09/2016